About TG Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.tgtherapeutics.com/
Frequently Asked Questions
What is the 52-week range for TGTX?
The 52-week high is $59.3 and the 52-week low is $26.76.
What is the P/E ratio for TGTX?
The Price to Earnings (P/E) ratio is 18.59.
What is the dividend yield for TGTX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 72.30%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 55.22%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 21.07.
Analyst Recommendation Trends
Wall Street analyst consensus for TGTX over the last few months:
Latest TGTX News
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach
B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.
Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine
Novo Nordisk A/Sâs 2030 pipeline targets, Wegovy pill growth and Q2 sales show major upside. Click for this NVO stock update.
Dow Jones Futures Fall After Nasdaq Hits New High; Sandisk, Micron Trigger Buy Signals
The Nasdaq hit a new high with memory giants Sandisk and Micron flashing buy signals. But financials are struggling.
Dow Jones Futures: Nasdaq Hits New High; Sandisk, Micron Trigger Buy Signals
The Nasdaq hit a new high with memory giants Sandisk and Micron flashing buy signals. But financials are struggling.
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup
TGTX pairs strong growth with a tightening base below resistance. See ChartMill’s breakout setup, key levels, risks, and position sizing.
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share
TG Therapeutics (NASDAQ:TGTX) Chairman, President and Chief Executive Officer Mike Weiss said the company’s multiple sclerosis therapy, BRIUMVI, has captured more than one-third of the intravenous anti-CD20 market and continues to gain share as it approaches its fourth full year on the market. Spea
TG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent Rebound
TG Therapeutics (TGTX) steps into the spotlight ahead of its H.C. Wainwright conference appearance on September 14, drawing fresh attention after the stock recently bounced off its 50-day moving average. Across the past few months, TG Therapeutics has leaned into stronger momentum, with a 30-day share price return of 12.36% and a year-to-date share price return of 92.86%. The one-year total shareholder return of 73.17% and roughly 5x three-year total shareholder return suggest earlier buyers...
Arcutis Biotherapeutics (ARQT) Moves 11.2% Higher: Will This Strength Last?
Arcutis Biotherapeutics (ARQT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Dow Jones Futures Rise After Hawkish Fed, Warsh Hit Stocks, Trump Fumes; AMD, Bloom Energy Eye Buy Points
The S&P 500 fell on the Fed rate hike and hawkish Warsh comments, But AMD, Bloom Energy flirted with buy signals.
TG Therapeutics Makes A Bullish Move Amid Ongoing Roche Rivalry
TG Therapeutics stock showed technical strength Wednesday, bounding off its 50-day moving average and nearing a breakout on the weekly chart.
Insider Decision: Laurence N Charney Offloads $274K Worth Of TG Therapeutics Stock
Laurence N Charney, Board Member at TG Therapeutics (NASDAQ:TGTX), reported an insider sell on September 14, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Fireside chat scheduled for Monday, September 14, 2026, at 12:00pm ETNEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the H.C. Wainwright 28th Annual Global Investment Conference, being held on September 14 - 16, 2026. The fireside chat is scheduled to take place on Monday, September 14, 2026, at 12:00pm ET. A live webcast of the fireside chat will be av
Kymera Therapeutics (KYMR) Up 10.2% Since Last Earnings Report: Can It Continue?
Kymera Therapeutics (KYMR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
Fireside chat scheduled for Wednesday, September 9, 2026, at 11:30am ETNEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Cantor Global Healthcare Conference, being held on September 9 - 11, 2026. The fireside chat is scheduled to take place on Wednesday, September 9, 2026, at 11:30am ET. A live webcast of the fireside chat will be available on the Eve
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-10 | Charney Laurence N | -5,000 | $54.96 | $274,800 |
| 2026-08-07 | Charney Laurence N | -450 | - | - |
| 2026-08-07 | Charney Laurence N | -500 | - | - |
| 2026-08-06 | Charney Laurence N | -5,100 | - | - |
| 2026-06-11 | Lonial Sagar | +8,325 | - | - |
| 2026-06-11 | HUME DANIEL | +8,325 | - | - |
| 2026-06-11 | Hoberman Kenneth | +8,325 | - | - |
| 2026-06-11 | Echelard Yann | +8,325 | - | - |
| 2026-06-11 | Charney Laurence N | +8,325 | - | - |
| 2026-01-29 | Charney Laurence N | -13,197 | - | - |
| 2026-01-28 | Charney Laurence N | -30,000 | - | - |
| 2026-01-08 | WEISS MICHAEL S | +622,000 | - | - |
| 2026-01-08 | Power Sean A | +90,000 | - | - |
| 2025-11-24 | Echelard Yann | -5,000 | $32.57 | $162,850 |
| 2025-11-05 | WEISS MICHAEL S | -803,717 | - | - |
| 2025-11-05 | WEISS MICHAEL S | -3,865,126 | - | - |